Eikon Therapeutics
About:
Eikon Therapeutics is a biopharmaceutical company that develops live-cell resolution microscopy and engineering for drug discovery.
Website: http://www.eikontx.com
Twitter/X: eikontx
Top Investors: StepStone Group, General Catalyst, Lux Capital, Schroders Capital, Innovation Endeavors
Description:
Eikon Therapeutics is a biopharmaceutical company employing revolutionary technology at the interface of biology, engineering, and chemistry to discover novel treatments for life-threatening diseases. Eikon’s discovery platform is built on groundbreaking innovations from its founders (Nobel Prize, 2014), culminating in the creation of microscopes that enable real-time, molecular-resolution measurements of protein movement in living cells.
$772M
$50M to $100M
Hayward, California, United States
2019-01-01
kheterpala(AT)eikontx.com
Eric Betzig, Luke Lavi, Robert Tjian, Xavier Darzacq
251-500
2023-06-01
Private
© 2025 bioDAO.ai